Home
BioCina

BioCina Market Share Analysis for June 2026

Insights from BioCina From process development to commercial manufacturing, learn more through our library of resources provided by our team of industry experts. Featured Resource About BioCina Video Learn about BioCina’s superior FDA and cGMP approved manufacturing development and manufacturing services. The Six Keys to Client Satisfaction in Biologics CDMO Services White Paper This article […]

Industry: N/A

Domainbiocina.com

Year Founded2020

Employees201 - 500

Annual Revenue--

BioCina

BioCina (including company regionals)

biocina.com

See more website traffic and engagement information

Total visits to BioCina's top domains

Understand BioCina market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biocina.com3.4K

See more with Sales Intelligence

Avg. visit duration in BioCina's top domains

Analyze BioCina engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biocina.com00:00:32

See more with Sales Intelligence

Avg. pageviews on BioCina's top domains

See how BioCina keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biocina.com1.94

See more with Sales Intelligence

BioCina top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by BioCina

These are the website technologies, by industry, used by BioCina top domains

Widget (8)

Twemoji

Content Management System (4)

WordPress

Conversion & Analytics (4)

Google Analytics

Payment & Currencies (4)

Cart Functionality

More Technologies

8

See all

News & Signals from BioCina

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioCina Pty Ltd. launches comprehensive manufacturing program for RLS-2201.BioCina Pty Ltd, a global Contract Development and Manufacturing Organisation (CDMO), has launched a comprehensive manufacturing program for RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys Ltd (ASX: PAB) for the acute treatment of delirium in intensive care.

NewsBioCina Pty Ltd. hired Thomas Broudy as Chief Executive Officer on Oct 28th '25.BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as Chief Executive Officer to lead the company's growth of its biologic drug substance and sterile drug product development and manufacturing services.

NewsPfizer Inc sold assets to BioCina Pty Ltd. on Jul 19th '20.Since acquiring the manufacturing plant from Pfizer in April 2023, BioCina Pty Ltd. has invested heavily into the site growing diverse CDMO capability and team.